DOI: 10.1055/s-00000071

Seminars in Neurology

References

Tüzün E, Meriggioli MN, Rowin J, Yang H, Christadoss P.
Myasthenia gravis patients with low plasma IL-6 and IFN-γ benefit from etanercept treatment.

J Autoimmun 2005;
24 (3) 261-268

Download Bibliographical Data

Search in:
Access: